This is the third in a series of three articles reporting results of the 1986 AMRA Manpower Survey. The purpose of this article is to provide information on the following non-management positions: coding, transcription, record deficiency analysis, release of information, record retrieval/filing, and general clerical. The first article described the survey and provided information on directors of medical record departments. The second article addressed other management positions in the medical record department.

Abstracting and Indexing↗

PubMed1987

Essentials: on the path to revision.

This article will discuss the organization, development and intended uses of Essentials, the minimum standards for accreditation of MRT and MRA programs.

Accreditation↗

PubMed1987

AMRA's commitment to entry-level education.

This is the second part of an informative discussion of where AMRA stands with Essentials and what AMRA members must do to bring Essentials into good standing for the 1990s.

Competency-Based Education↗

PubMed1986

Observation of A dependence in Koba-Nielsen-Olesen scaling distributions for high-energy hadron-nucleus interactions.

Explore the source record for details and available documents.

Journal Article↗

PubMed1985

Serological markers of hepatitis B infection in Niue children.

Hepatitis B infection is hyperendemic in the adult population of Niue. In order to determine the age at which infection is acquired and the contribution of vertical and horizontal transmission, the sera from 1055 children were tested for markers of hepatitis B infection. Eleven percent (11.0%) were found to be carriers of hepatitis B surface antigen (HBsAg) and a further 33.6% had antibody to hepatitis B surface antigen (anti-HBs). While less than 15% of the population were infected before the age of two years, these children had the greatest risk of becoming chronic carriers. The simplest method of controlling hepatitis B infection in Niue would be to immunise all newborn babies.

Adolescent↗

PubMed1981

The effect of counseling by a pharmacist on drug compliance in elderly patients.

The effect of counselling by a pharmacist on medication errors was assessed in fifty-three patients aged 65 years and over attending a day hospital. Despite random allocation to either the counselled or the uncounselled ('control') group, patients in the counselled group were making fewer errors than those in the control group even before they received instruction from the pharmacist. There was no evidence that those in the counselled group made fewer errors for complied better with their treatment as a result of counselling.

Aged↗

PubMedDate not supplied

Mobilizing training resources for rural foster parents, adoptive parents, and applicants in Oregon, U.S.A.

This article describes a program for legally mandated training of foster and adoptive applicants and parents across a vast rural territory. The development of this varied program and its funding sources can serve as an example for other rural areas.

Adoption↗

PubMedDate not supplied

Single-dose, placebo-controlled, phase I study of oral dolasetron.

STUDY OBJECTIVES: To evaluate the safety, tolerability, and pharmacokinetics of single, escalating doses of oral dolasetron mesylate, a new 5-HT3 receptor antagonist. DESIGN: Double-blind, placebo-controlled, dose-escalating phase I study. SETTING: A clinical research center. PATIENTS: One hundred twenty healthy male volunteers. INTERVENTIONS: Subjects received either placebo or oral dolasetron mesylate 50, 100, 150, 200, 250, 300, or 400 mg. MEASUREMENTS AND MAIN RESULTS: Compared with placebo, subjects receiving dolasetron mesylate reported a greater frequency of headache, light-headedness, dizziness, increased appetite, and nausea. There were no clinically significant changes in mean laboratory values from before to after treatment. Adverse events were transient, mild or moderate, and similar to those after single intravenous doses of the drug. No clinically significant electrocardiographic changes occurred, but lengthening of the QRS complex duration and dose-dependent lengthening of PR and QTc intervals were observed 1-2 hours after dosing. These effects were asymptomatic and were mainly associated with higher doses (< or = 300 mg). CONCLUSION: Dolasetron mesylate is well tolerated when administered in single oral doses up to 400 mg to healthy volunteers. Clinical trials are under way to evaluate the agent's efficacy in preventing chemotherapy-induced and postoperative nausea and vomiting with doses up to 200 mg.

Administration, Oral↗